Medicare limits coverage of $28,000-a-year Alzheimer's drug Medicare said Tuesday it will limit coverage of a $28,000-a-year Alzheimer's drug whose benefits have been widely questioned, a major development in the nation's tug-of-war over the fair value of new medicines that offer tantalizing possibilities but come with prohibitive prices. Health 12 Jan, 2022
FDA trims use of contentious Alzheimer's drug amid backlash A month after approving a controversial new Alzheimer's drug, U.S. health regulators on Thursday signed off on new prescribing instructions that are likely to limit its use. World 09 Jul, 2021
